全文获取类型
收费全文 | 81608篇 |
免费 | 8152篇 |
国内免费 | 187篇 |
专业分类
耳鼻咽喉 | 1178篇 |
儿科学 | 2473篇 |
妇产科学 | 1787篇 |
基础医学 | 11643篇 |
口腔科学 | 1991篇 |
临床医学 | 10025篇 |
内科学 | 14232篇 |
皮肤病学 | 1291篇 |
神经病学 | 6629篇 |
特种医学 | 2826篇 |
外国民族医学 | 10篇 |
外科学 | 11357篇 |
综合类 | 1664篇 |
一般理论 | 67篇 |
预防医学 | 9292篇 |
眼科学 | 1846篇 |
药学 | 6711篇 |
1篇 | |
中国医学 | 77篇 |
肿瘤学 | 4847篇 |
出版年
2021年 | 880篇 |
2020年 | 728篇 |
2019年 | 1109篇 |
2018年 | 1377篇 |
2017年 | 999篇 |
2016年 | 1073篇 |
2015年 | 1235篇 |
2014年 | 1616篇 |
2013年 | 2560篇 |
2012年 | 3458篇 |
2011年 | 3737篇 |
2010年 | 1973篇 |
2009年 | 1899篇 |
2008年 | 3218篇 |
2007年 | 3557篇 |
2006年 | 3403篇 |
2005年 | 3477篇 |
2004年 | 3242篇 |
2003年 | 3012篇 |
2002年 | 2947篇 |
2001年 | 2703篇 |
2000年 | 2809篇 |
1999年 | 2455篇 |
1998年 | 983篇 |
1997年 | 782篇 |
1996年 | 793篇 |
1995年 | 786篇 |
1994年 | 802篇 |
1993年 | 739篇 |
1992年 | 2086篇 |
1991年 | 2016篇 |
1990年 | 1898篇 |
1989年 | 1867篇 |
1988年 | 1769篇 |
1987年 | 1782篇 |
1986年 | 1681篇 |
1985年 | 1665篇 |
1984年 | 1382篇 |
1983年 | 1248篇 |
1982年 | 837篇 |
1981年 | 717篇 |
1979年 | 1209篇 |
1978年 | 869篇 |
1977年 | 759篇 |
1976年 | 710篇 |
1975年 | 711篇 |
1974年 | 859篇 |
1973年 | 748篇 |
1972年 | 731篇 |
1971年 | 637篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Tyler B. Kratzer MPH Ahmedin Jemal DVM PhD Kimberly D. Miller MPH Sarah Nash PhD Charles Wiggins PhD Diana Redwood PhD Robert Smith PhD Rebecca L. Siegel MPH 《CA: a cancer journal for clinicians》2023,73(2):120-146
American Indian and Alaska Native (AIAN) individuals are diverse culturally and geographically but share a high prevalence of chronic illness, largely because of obstacles to high-quality health care. The authors comprehensively examined cancer incidence and mortality among non-Hispanic AIAN individuals, compared with non-Hispanic White individuals for context, using population-based data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries. Overall cancer rates among AIAN individuals were 2% higher than among White individuals for incidence (2014 through 2018, confined to Purchased/Referred Care Delivery Area counties to reduce racial misclassification) but 18% higher for mortality (2015 through 2019). However, disparities varied widely by cancer type and geographic region. For example, breast and prostate cancer mortality rates are 8% and 31% higher, respectively, in AIAN individuals than in White individuals despite lower incidence and the availability of early detection tests for these cancers. The burden among AIAN individuals is highest for infection-related cancers (liver, stomach, and cervix), for kidney cancer, and for colorectal cancer among indigenous Alaskans (91.3 vs. 35.5 cases per 100,000 for White Alaskans), who have the highest rates in the world. Steep increases for early onset colorectal cancer, from 18.8 cases per 100,000 Native Alaskans aged 20–49 years during 1998 through 2002 to 34.8 cases per 100,000 during 2014 through 2018, exacerbated this disparity. Death rates for infection-related cancers (liver, stomach, and cervix), as well as kidney cancer, were approximately two-fold higher among AIAN individuals compared with White individuals. These findings highlight the need for more effective strategies to reduce the prevalence of chronic oncogenic infections and improve access to high-quality cancer screening and treatment for AIAN individuals. Mitigating the disparate burden will require expanded financial support of tribal health care as well as increased collaboration and engagement with this marginalized population. 相似文献
2.
Alzina Koric MPP Chun-Pin Chang PhD Bayarmaa Mark MS Kerry Rowe PhD John Snyder PhD Mark Dodson MD Vikrant G. Deshmukh PhD Michael G. Newman MS Alison M. Fraser MPH Ken R. Smith PhD Ankita P. Date MS Lisa H. Gren PhD Christina A. Porucznik PhD Benjamin A. Haaland PhD N. Lynn Henry MD Mia Hashibe PhD 《Cancer》2022,128(14):2826-2835
3.
Tymms Kathleen Butcher Belinda E. Sletten Tracey L. Smith Tegan O’Sullivan Catherine Littlejohn Geoffrey Sadler Ricky Tronnberg Rebecca Griffiths Hedley 《Clinical rheumatology》2022,41(4):1105-1114
Clinical Rheumatology - Sleep disturbance and fatigue are commonly reported in ankylosing spondylitis (AS) but specific prevalence and the relationship to disease control are unknown. This... 相似文献
4.
5.
Obi Chukwuemeka Smith Alexander T. Hughes Gregory J. Adeboye Adedayo A. 《Heart failure reviews》2022,27(5):1925-1932
Heart Failure Reviews - Although currently employed therapies for heart failure decrease overall mortality and improve patient quality of life temporarily, the disease is known to progress even for... 相似文献
6.
Chen Ciao-Sin Smith Ellen M. Lavoie Stringer Kathleen A. Henry N. Lynn Hertz Daniel L. 《Breast cancer research and treatment》2022,194(3):551-560
Breast Cancer Research and Treatment - Chemotherapy-induced peripheral neuropathy (CIPN) is the major treatment-limiting toxicity of paclitaxel, which predominantly presents as sensory symptoms,... 相似文献
7.
8.
Stephanie H. Ameis John D. Haltigan Rachael E. Lyon Amanda Sawyer Pat Mirenda Connor M. Kerns Isabel M. Smith Tracy Vaillancourt Joanne Volden Charlotte Waddell Lonnie Zwaigenbaum Teresa Bennett Eric Duku Mayada Elsabbagh Stelios Georgiades Wendy J. Ungar Anat Zaidman-Zait Meng-Chuan Lai Peter Szatmari for the Pathways in ASD Study Team 《Journal of child psychology and psychiatry, and allied disciplines》2022,63(5):553-562
9.
Jacey Nishiguchi Anusha McNamara Colleen S. Surlyn Kellene Vokaty Eagen Laura Feeney Vivian Lian David E. Smith 《Journal of viral hepatitis》2022,29(1):21-25
In 2016, an eConsult service was developed within a safety net health system to expand access to hepatitis C (HCV) treatment in the primary care setting. The eConsult system provides individualized treatment recommendations from specially trained primary care pharmacists and primary care physicians to primary care providers with less experience in the rapidly changing treatment of HCV. Since its launch, this service has had a large impact in expanding care to a largely homeless and low-income urban population within our health system. We now aim to evaluate its efficacy in curing HCV. In this retrospective cohort study, we describe rates of sustained virologic response 12 weeks after treatment completion (SVR12) for those who received primary care-based HCV treatment through the eConsult system with those who were treated in primary care independent of an eConsult from 2017 to 2019. We found there was no significant difference in the proportion of patients who achieved SVR12 between the two groups. Overall, >90% of patients who received treatment achieved SVR12. Approximately 40% of patients treated for HCV received an eConsult, suggesting utility of the eConsult in expanding access and coordinating treatment for patients within our network. 相似文献
10.